JH HOLDING LIMITED

Executive Summary

JH HOLDING LIMITED is financially healthy with strong liquidity and growing equity, positioning it well within its micro-entity scale. The company operates with lean resources but maintains robust working capital and a positive growth trend. Focused efforts on diversification and scaling can further enhance its financial resilience and long-term sustainability.

JH HOLDING LIMITED - Analysis Report

Company Number: 13030411

Analysis Date: 2025-07-20 14:29 UTC

Financial Health Assessment of JH HOLDING LIMITED

---

1. Financial Health Score: B+

Explanation:
JH HOLDING LIMITED demonstrates a strong and improving financial position, particularly notable for a micro-entity. The company has consistently grown its net current assets and net assets over the past five years, indicating good working capital management and retained earnings. However, as a micro-entity with limited scale and a small employee base, growth potential and operational diversification remain constrained, which tempers the rating slightly.

---

2. Key Vital Signs

Metric	Latest (2024)	Interpretation
Current Assets	£170,953	Healthy liquidity reservoir to meet short-term obligations.
Current Liabilities	£31,196	Manageable short-term debts; increased but supported by asset growth.
Net Current Assets	£139,757	Strong working capital, indicating operational liquidity.
Net Assets (Equity)	£138,143	Positive and growing shareholders’ funds, signaling retained profits and capital stability.
Employee Count	1	Very lean operation, low fixed overheads but limited scalability.
Account Category	Micro	Simplified reporting, small size business with minimal complexity.

Interpretation:

• Healthy Cash Flow Indicators: The substantial net current assets suggest the company can comfortably cover immediate liabilities, a key sign of financial wellness akin to a patient with a strong pulse and stable vital signs.
• Growth Trend: Net assets have increased by approximately 4.5 times since 2020, reflecting accumulated profits or retained earnings, which is a positive symptom indicating effective management.
• Risk Factors: The small employee base and micro-entity status may limit operational capacity and resilience to market shocks, similar to a patient with a strong heart but low muscle mass—strong but with limited endurance.

---

3. Diagnosis

JH HOLDING LIMITED shows signs of robust financial health for its size and category. The company maintains a solid liquidity position and positive equity growth, which indicates good financial stewardship and operational control. The micro-entity status and single employee imply a lean business model, likely focused on a specialized service, consistent with its SIC code for general medical practice activities.

No symptoms of financial distress such as negative working capital, shrinking equity, or overdue filings are present. The increase in current liabilities in 2024 is offset by a proportionally larger increase in current assets, maintaining a strong net current asset position.

From a financial wellness perspective, the business resembles a patient with stable vitals and good recovery trajectory, but with room for building strength and resilience to future challenges.

---

4. Recommendations

• Maintain Strong Liquidity: Continue managing receivables and payables efficiently to preserve healthy working capital, ensuring the business can absorb short-term shocks.
• Diversify Revenue Streams: Explore opportunities to expand services or client base to mitigate risk from over-reliance on limited operations, akin to improving muscle strength for better endurance.
• Plan for Growth: Consider gradual scaling by increasing staff or investing in assets to enhance capacity, while monitoring cost control to avoid overextension.
• Regular Financial Reviews: Keep up-to-date financial monitoring and timely filing to maintain compliance and early detection of any financial "symptoms" that may arise.
• Build Reserves: Strengthen retained earnings or cash reserves as a buffer for future uncertainties, improving the company’s financial immune system.

---